Texas Attorney General Ken Paxton is filing a lawsuit against the makers of Tylenol, asserting the corporations hid safety concerns that the pain reliever created to pediatric cognitive development.
The court filing arrives a month after President Donald Trump promoted an unsubstantiated connection between using acetaminophen - alternatively called paracetamol - while pregnant and autism spectrum disorder in children.
The attorney general is suing the pharmaceutical giant, which formerly manufactured the medication, the sole analgesic approved for pregnant women, and the current manufacturer, which currently produces it.
In a official comment, he said they "betrayed America by making money from discomfort and promoting medication regardless of the dangers."
Kenvue asserts there is insufficient reliable data linking Tylenol to autism spectrum disorder.
"These manufacturers deceived for years, knowingly endangering numerous people to increase profits," Paxton, a Republican, declared.
Kenvue said in a statement that it was "seriously troubled by the dissemination of inaccurate information on the reliability of paracetamol and the possible consequences that could have on the welfare of American women and children."
On its online platform, Kenvue also said it had "regularly reviewed the pertinent research and there is insufficient valid information that demonstrates a verified association between consuming acetaminophen and autism spectrum disorder."
Associations representing doctors and medical practitioners agree.
The leading OB-GYN organization has declared acetaminophen - the key substance in acetaminophen - is a restricted selection for women during pregnancy to address discomfort and fever, which can pose major wellness concerns if left untreated.
"In more than two decades of investigation on the use of paracetamol in gestation, not a single reputable study has conclusively proven that the consumption of acetaminophen in any period of pregnancy causes neurological conditions in children," the association said.
The court filing cites recent announcements from the former administration in arguing the drug is reportedly hazardous.
Last month, the former president raised alarms from public health officials when he told pregnant women to "resist strongly" not to use Tylenol when ill.
The US Food and Drug Administration then issued a notice that medical professionals should think about restricting the use of Tylenol, while also declaring that "a proven link" between the medication and autism in children has not been established.
The Health Department head Kennedy, who oversees the FDA, had pledged in April to conduct "extensive scientific investigation" that would identify the source of autism spectrum disorder in a short period.
But authorities cautioned that discovering a unique factor of autism - believed by scientists to be the consequence of a complex mix of genetic and external influences - would be difficult.
Autism spectrum disorder is a form of lifelong neurodivergence and disability that affects how persons experience and interact with the environment, and is recognized using physician assessments.
In his court filing, the attorney general - a Trump ally who is campaigning for federal office - claims the manufacturer and Johnson & Johnson "intentionally overlooked and sought to suppress the research" around acetaminophen and autism spectrum disorder.
The case attempts to require the corporations "remove any commercial messaging" that asserts Tylenol is reliable for pregnant women.
The court case parallels the grievances of a assembly of mothers and fathers of young ones with autism spectrum disorder and ADHD who took legal action against the manufacturers of Tylenol in two years ago.
A federal judge threw out the lawsuit, stating investigations from the family's specialists was lacking definitive proof.
A tech enthusiast and writer passionate about exploring the latest innovations and sharing practical lifestyle advice.